Englewood Lab Balance Sheet Health
Financial Health criteria checks 6/6
Englewood Lab has a total shareholder equity of ₩130.5B and total debt of ₩12.7B, which brings its debt-to-equity ratio to 9.7%. Its total assets and total liabilities are ₩177.8B and ₩47.3B respectively. Englewood Lab's EBIT is ₩28.0B making its interest coverage ratio 160.4. It has cash and short-term investments of ₩17.3B.
Key information
9.7%
Debt to equity ratio
₩12.70b
Debt
| Interest coverage ratio | 160.4x |
| Cash | ₩17.26b |
| Equity | ₩130.47b |
| Total liabilities | ₩47.29b |
| Total assets | ₩177.76b |
Recent financial health updates
We Think Englewood Lab (KOSDAQ:950140) Can Manage Its Debt With Ease
Jun 20
These 4 Measures Indicate That Englewood Lab (KOSDAQ:950140) Is Using Debt Reasonably Well
Feb 05
Recent updates
Englewood Lab, Inc. (KOSDAQ:950140) Might Not Be As Mispriced As It Looks After Plunging 30%
Nov 11Not Many Are Piling Into Englewood Lab, Inc. (KOSDAQ:950140) Stock Yet As It Plummets 30%
Nov 11Englewood Lab, Inc. (KOSDAQ:950140) Stocks Pounded By 28% But Not Lagging Market On Growth Or Pricing
Aug 07We Think Englewood Lab (KOSDAQ:950140) Can Manage Its Debt With Ease
Jun 20Is Now The Time To Put Englewood Lab (KOSDAQ:950140) On Your Watchlist?
May 24A Piece Of The Puzzle Missing From Englewood Lab, Inc.'s (KOSDAQ:950140) 25% Share Price Climb
May 09Investors Shouldn't Overlook Englewood Lab's (KOSDAQ:950140) Impressive Returns On Capital
May 08When Should You Buy Englewood Lab, Inc. (KOSDAQ:950140)?
Apr 16There Are Reasons To Feel Uneasy About Englewood Lab's (KOSDAQ:950140) Returns On Capital
Mar 31If You Had Bought Englewood Lab (KOSDAQ:950140) Shares A Year Ago You'd Have Earned 106% Returns
Mar 17What Kind Of Shareholders Hold The Majority In Englewood Lab, Inc.'s (KOSDAQ:950140) Shares?
Feb 23These 4 Measures Indicate That Englewood Lab (KOSDAQ:950140) Is Using Debt Reasonably Well
Feb 05Englewood Lab, Inc. (KOSDAQ:950140) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Jan 20Is Englewood Lab, Inc. (KOSDAQ:950140) Potentially Undervalued?
Jan 02Returns On Capital At Englewood Lab (KOSDAQ:950140) Paint An Interesting Picture
Dec 15Are Englewood Lab's (KOSDAQ:950140) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Nov 26Financial Position Analysis
Short Term Liabilities: A950140's short term assets (₩131.0B) exceed its short term liabilities (₩40.2B).
Long Term Liabilities: A950140's short term assets (₩131.0B) exceed its long term liabilities (₩7.1B).
Debt to Equity History and Analysis
Debt Level: A950140 has more cash than its total debt.
Reducing Debt: A950140's debt to equity ratio has reduced from 43% to 9.7% over the past 5 years.
Debt Coverage: A950140's debt is well covered by operating cash flow (60.2%).
Interest Coverage: A950140's interest payments on its debt are well covered by EBIT (160.4x coverage).